Navigation Links
Yosef Shiloh, Ph.D., receives the 51st Annual AACR G.H.A. Clowes Memorial Award
Date:1/31/2011

ORLANDO, Fla. Yosef Shiloh, Ph.D., a David and Inez Myers professor in cancer research in the department of human molecular genetics and biochemistry in the Sackler School of Medicine at Tel Aviv University, Israel, will receive the 51st Annual AACR G.H.A. Clowes Memorial Award for his studies of the cellular DNA damage response and the rare genomic instability syndrome ataxia-telangiectasia (A-T).

"Dr. Shiloh is an international leader in the study of A-T, and his identification and cloning of the A-T gene provided for the first time a definitive diagnosis for so many who had gone without one," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "This discovery, along with his subsequent work, has played a critical role in increasing our understanding of DNA damage response and repair, which has important implications for cancer and other diseases. Dr. Shiloh is a truly exceptional scientist and we congratulate him on receiving the G.H.A. Clowes Memorial Award."

Patients with A-T exhibit progressive neurodegeneration, immunodeficiency, striking cancer predisposition and chromosomal fragility. The disease is caused by a profound defect in a major mechanism that maintains genomic stability the cellular response to DNA double strand breaks.

For over 30 years Shiloh has been investigating A-T and the defect in the DNA damage response that leads to this disease. He changed the field when his lab identified the A-T gene in 1995 and successfully cloned it, calling it ataxia-telangiectasia mutated (ATM). The identification of the ATM gene revolutionized the field, opening many new avenues of inquiry and allowing research to race forward.

Since then, the Shiloh laboratory has expanded its studies to the mode of action of the ATM gene product the ATM protein kinase and the extensive signaling network that it activates in response to DNA damage. A leader in this field, Shiloh's work has made a major impact on the scientific understanding of the cellular response to genotoxic stress. This, in turn, has led to the discovery of many new genes and processes with critical roles in human biology and cancer.

Shiloh earned an undergraduate degree from The Technion - Israel Institute of Technology in 1974, a Master of Science in human genetics from The Hebrew University of Jerusalem in 1977 and his doctorate in human genetics from The Hebrew University of Jerusalem in 1983.

From 1983 to 1985 he was a research fellow at Harvard Medical School and The Children's Hospital of Boston. He joined Tel Aviv University in 1985 as a senior lecturer of human genetics and was an associate professor there from 1989 to 1995. He has been a professor of human genetics at Tel Aviv University Sackler School of Medicine since 1995 and served as chairman of the department of human genetics and molecular medicine from 2002 through 2005.

Shiloh is also research professor of the Israel Cancer Research Fund, and a member of the American Association of Cancer Research and numerous editorial boards and organizations, among them the Israel National Academy of Sciences and Humanities, the American Society of Human Genetics, the European Molecular Biology Organization, the European Association of Cancer Research, and the Human Genome Organization. His work has earned him many awards and honors, including the American Cancer Society International Research Fellowship, Teva Pharmaceutical Industries Prize in Biomedical Research, the Fogarty Scholarship at the National Institutes of Health and the EMET Prize in Life Sciences, awarded by The A.M.N. Foundation for the Advancement of Science, Art and Culture and the Prime Minister of the State of Israel.

The American Association for Cancer Research and Eli Lilly and Company established the G.H.A. Clowes Memorial Award in 1961 to honor G.H.A. Clowes, a founding member of the AACR. This honor recognizes and individual with outstanding recent accomplishments in basic cancer research.

Shiloh's lecture, "Mining rare genetic disorders for new insights into human biology: lessons from ataxia-telangiectasia," will take place at 3:30 p.m. on Monday, Apr. 4 at the AACR 102nd Annual Meeting 2011 in the Orange County Convention Center, Orlando, Fla.


'/>"/>

Contact: Michele Sharp
michele.sharp@aacr.org
267-646-0622
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
2. AnaLisa DiFeo, Ph.D., recognized with the Liz Tilberis Scholarship
3. Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist
4. Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial
5. UIC Center for Research on Women and Gender receives Presidential Award
6. LA BioMed researcher receives Lifetime Achievement Award
7. Case Western Reserve receives $7.8M to study manic symptoms in children
8. Liverpool receives $1.5M to tackle disease in Africa
9. Case Western Reserve receives $10M to study retinal disease, develop new treatments
10. University of Houston receives $5 million grant from Houston Endowment
11. BMC radiologist receives 2010 Marie Sklodowska-Curie Award from AAWR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Doctors on Liens has ... by Dr. Kendell Mendonca , to its growing network of doctors in Central ... injuries stemming from car accidents such as whiplash, back pain, neck pain, hip and ...
(Date:2/21/2017)... Carrollton, Ga. (PRWEB) , ... February 21, 2017 , ... ... industry. To simplify the secure exchange of data across industry solutions, Fogo Data ... in the power of community. A healthy community is one in which all ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... the predictive analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to ... backed by giants including Accenture, GE Ventures, and Software AG , will ...
(Date:2/21/2017)... ... February 21, 2017 , ... CLICKco LLC, a company dedicated ... are now available for purchase on RonnieColemanNutrition.com, a popular website for health and ... health-conscious consumers who love coffee but are looking to add more protein to ...
(Date:2/20/2017)... ... , ... Nancy Johnston Toll marks her debut in the publishing ... Bump in the Road ” (published by Xlibris). Inspired from her personal experiences, this ... ups and downs experienced by anyone going through cancer treatment and how one can ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... JOSE, Calif. , Feb. 21, 2017 Cadence ... that its Cadence ® Tensilica ® Fusion F1 ... ™ MAC IP offering. The licensable IP targets SoCs ... city and industrial applications. M2B leveraged the Fusion F1 DSP ... run value-added applications like voice trigger, audio identification and sensor ...
(Date:2/21/2017)... Research and Markets has announced the addition of the "Liver Cirrhosis ... ... Cirrhosis Drugs Price Analysis and Strategies - 2016, provides drug pricing data ... answers the following questions: What are the key ... positioned in the Global Liver Cirrhosis market? What are ...
(Date:2/21/2017)... , Feb. 21, 2017 Research and Markets has ... - 2016" report to their offering. ... The latest research Rosacea Drugs Price Analysis and Strategies ... market. The research answers the following questions: ... attributes? How are they positioned in the Global Rosacea market? ...
Breaking Medicine Technology: